NasdaqGM - Nasdaq Real Time Price
USD
ABIVAX Société Anonyme (ABVX)
115.88
+4.79
(+4.31%)
As of 11:33:16 AM EDT. Market Open.
Trade Abivax on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for ABVX
What's happening with ABVX?
Powered by Yahoo ScoutAbivax is actively advancing its clinical programs, highlighted by a new collaboration with Roche for a Phase 1b trial of rupitasertib in breast cancer. The company is also preparing for a pivotal NDA submission for its lead drug obefazimod by the end of 2026, while enhancing its commercial leadership to support potential market entry.
Powered by Yahoo Scout
- Previous Close
111.08 - Open
112.31 - Bid 121.16 x 100
- Ask 119.33 x 100
- Day's Range
112.20 - 116.10 - 52 Week Range
69.81 - 148.83 - Volume
337,555 - Avg. Volume
1,552,507 - Market Cap (intraday)
10.111B - Beta (5Y Monthly) -0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-5.23 - Earnings Date Sep 21, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
165.91
Recent News
View More
Performance Overview
Trailing total returns as of 9/3/2026, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
ABVX
16.24%
CAC 40 (^FCHI)
1.57%
1-Year Return
ABVX
41.33%
CAC 40 (^FCHI)
7.23%
3-Year Return
ABVX
898.92%
CAC 40 (^FCHI)
13.45%
5-Year Return
ABVX
898.92%
CAC 40 (^FCHI)
23.73%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 9/1/2026
-
Market Cap
9.98B
-
Enterprise Value
9.41B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
19.92
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-44.65%
-
Return on Equity (ttm)
-157.07%
-
Revenue (ttm)
4.92M
-
Net Income Avi to Common (ttm)
-332.2M
-
Diluted EPS (ttm)
-5.23
Balance Sheet and Cash Flow
-
Total Cash (mrq)
491.55M
-
Total Debt/Equity (mrq)
7.96%
-
Levered Free Cash Flow (ttm)
-114.47M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
